UNSPSC 51282943: Rufloxacin

This classification denotes a quinolone antibiotic with the molecular formula C17H18FN3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y521XM2900, chemically known as 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid but generally known as rufloxacin, which bears US NIH Compound Identifier 58258. European Medicines Agency schedules Rufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10404MIG.

UNSPSC 51282943 Rufloxacin, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two recent opportunities tagged under this code do not involve rufloxacin procurement; instead, they reflect pharmaceutical warehouse supply and public-health product acquisition more broadly. The Illinois Department of Public Health awarded a piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems. When state and local solicitations are tagged with a pharmaceutical commodity code, they typically reflect antibiotic or emergency-response product supply through cooperative purchasing vehicles or direct competitive bids, often with quarterly or routine delivery schedules and multi-year terms that include renewal options. Issuing bodies in the recent record include state health departments and county health/community services agencies; both are routine buyers of pharmaceutical products through established vendor networks and procurement consortia.

Recent activity appears concentrated in Florida and Illinois, with the Illinois Department of Public Health and Seminole County representing the named parties. The Illinois piggyback award to Chartwell Rx LLC involved a $2,999,999.11 total contract value over three years with 12-month initial and renewal terms, awarded through an Invitation for Bid process with no set-aside or domestic-preference requirements. The Seminole County procurement, posted June 30, 2026, with a response deadline of July 26, 2026, sought annual supply of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, a two-year initial term plus one-year renewal option, and potential FEMA funding. The code shows limited recent volume and no open solicitations currently active; activity is sporadic and issuer-specific rather than a routine procurement category across multiple jurisdictions.